Skip to content

Salarius

  • About Us
    • Overview
    • Leadership Team
    • Board of Directors
  • Our Programs
    • Epigenetics
    • LSD1
    • Pipeline
    • Publications
    • Clinical Trials
  • News & Events
    • Press Releases
    • Events
    • In the News
  • Investors
    • Overview
    • Corporate Governance
      • Corporate Governance
      • Committee Composition
    • Press Releases
    • In The News
    • Financial Reports
      • Annual Reports
      • Quarterly & Other Reports
      • Tax Documents
    • SEC Filings
    • Events & Presentations
    • Investor Resources
      • Investor FAQs
      • Information Request
      • E-mail Alerts
      • Contact IR
    • Stock Information
      • Stock Quote
      • Stock Chart
      • Historical Price Lookup
    • Analyst Coverage
  • Contact Us
Search

Our Programs

  • Epigenetics
  • LSD1
  • Pipeline
  • Publications
  • Clinical Trials

Our Programs

Salarius is developing targeted treatments for patients who need them the most.

 

  • Epigenetics

    Learn More

  • LSD1

    Learn More

  • Pipeline

    Learn More

  • Publications

    Learn More

  • Clinical Trials

    Learn More

Salarius

  • About Us
    • Overview
    • Leadership Team
    • Board of Directors
    • Scientific Advisors
  • Our Programs
    • Epigenetics
    • LSD1
    • Pipeline
    • Publications
    • Clinical Trials
  • News & Events
    • Press Releases
    • Events
    • In the News
  • Investors
    • Overview
    • Corporate Governance
    • Press Releases
    • In The News
    • Financial Reports
    • SEC Filings
    • Events & Presentations
    • Investor Resources
    • Stock Information
    • Analyst Coverage
  • Contact Us
  • Like Us on Facebook
  • Follow Us on Twitter
  • Connect on LinkedIn
© 2021 Salarius Pharmaceuticals, Inc. All Rights Reserved. Privacy and Terms of Use